← Evidence map

ReviewHaematologica2021

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications.

David M Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33472356